Position history for Candriam S.C.A.'s holdings in REGENERON PHARMACEUTICALS
Candriam S.C.A. holds 205,332 shares of REGN (REGENERON PHARMACEUTICALS), worth $158.5M as of 2025-Q4. The position was increased (++21.1% shares). REGN represents 0.8% of Candriam S.C.A.'s portfolio.
Current Value
$158.5M
Current Shares
205,332
Total Value Change
-$52.4M
Total Shares Change
+4,624
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 205,332 |
+21.1% |
| $158.5M |
| 0.8% |
| $773.94 |
51 |
| 2025-Q3 | Increased | 169,495 | +19.2% | $95.3M | 0.5% | $560.05 | 42 |
| 2025-Q2 | Decreased | 142,208 | -33.8% | $74.7M | 0.4% | $519.56 | 0 |
| 2025-Q1 | Decreased | 214,941 | -17.8% | $136.3M | 0.9% | $634.66 | 0 |
| 2024-Q4 | Increased | 261,498 | +3.5% | $186.3M | 1.1% | $698.71 | 50 |
| 2024-Q3 | Increased | 252,525 | +25.8% | $265.5M | 1.5% | $1,036.94 | 60 |
| 2024-Q2 | Decreased | 200,708 | -7.8% | $210.9M | 1.3% | $1,045.23 | 0 |